What is the optimal glucose-lowering therapy in the three commonest subtypes of autosomal dominant familial diabetes (MODY): GCK-related hyperglycemia, HNF1A-diabetes, and HNF4A-diabetes? This evidence concerns the gene HNF1A and diabetes mellitus.